Algeta ASA

oslo : ALGETA


August 12, 2013 01:13 ET

Algeta to Participate in Upcoming Investor Conferences

OSLO, NORWAY--(Marketwired - Aug 12, 2013) - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces that members of its executive management team will participate in the following upcoming investor conferences:

Wedbush Life Sciences Management Access Conference

Date: 13-14 August 2013

Participants:

Andrew Kay (President & CEO)

Oystein Soug (CFO)

Mike Booth (SVP, Communications)

Presentation date: Tuesday 13 August 2013

Venue: New York City, NY, USA


Morgan Stanley Global Healthcare Conference

Date: 9-11 September 2013

Participants:

Andrew Kay (President & CEO)

Oystein Soug (CFO)

Mike Booth (SVP, Communications)

Presentation date: Monday 9 September 2013

Venue: New York City, NY, USA


J.P. Morgan Cazenove London Small/Mid-Cap 1x1 Conference

Date: 11-12 September 2013

Participants:

Oystein Soug (CFO)

Mike Booth (SVP, Communications)

Venue: London, UK


Bank of America Merrill Lynch Global Healthcare Conference

Date: 11-13 September 2013

Participants:

Oystein Soug (CFO)

Mike Booth (SVP, Communications)

Presentation date: Friday 13 September 2013

Venue: London, UK

Presentations, where applicable, will be available to download at www.algeta.com following these events.

About Algeta

Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit www.algeta.com.

Press release:

http://hugin.info/134655/R/1721685/573429.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Algeta ASA via Thomson Reuters ONE

[HUG#1721685]

Contact Information


  • For further information, please contact:
    Mike Booth / Renate Birkeli
    Communications & Corporate Affairs
    +47 23 00 67 32
    Email Contact

    Media enquiries:

    Mark Swallow
    Citigate Dewe Rogerson
    +44 207 638 9571
    Email Contact

    Knut Ekern
    Gambit Hill & Knowlton
    +47 22 04 82 00
    Email Contact

    Kari Watson
    MacDougall Biomedical Communications
    +1 781 235 3060
    Email Contact

    US investor enquiries:
    Tricia Swanson
    The Trout Group
    +1 646 378 2953
    Email Contact